Denis Monnaie

Denis Monnaie has a diverse work experience spanning across various companies and roles. Denis is currently working at bioMérieux as the Vice President, General Manager, Clinical Operation Benelux Nordics since July 2022. Prior to this, they held the position of Sr Marketing Director Clinical Operations | Northern Europe at bioMérieux, where they led the Northern Europe marketing team and played a key role in promoting the Clinical portfolio in Microbiology, Molecular Biology, and ImmunoAssay.

Before joining bioMérieux, Denis worked at Ipsen for several years. Denis'sroles at Ipsen included Director, Corporate Strategy & Transformation, where they supported the Executive Leadership Team in decision-making and led strategic and transformation projects. Denis also served as the Business Unit Head for Oncology & Rare Diseases, Business Unit Head for Established Brands - Commercial Excellence Lead, Chief of Staff for EVP Specialty Care Commercial Operations, Finance Director for Brazil, Finance Director for Nordics, and Financial Controller for Eastern Europe.

Denis has experience outside of the pharmaceutical industry as well. Denis worked as a Business Controller at Proximus, where they provided critical insight information and performed profitability analysis. Additionally, they served as the Finance Officer for France at Tennant Company.

Throughout their career, Denis has demonstrated strong leadership skills and has been a member of various leadership teams. Denis has a proven track record of driving growth and transformation initiatives in global and regional roles.

Denis Monnaie obtained an MBA in Business Administration and Management, General from Arkansas State University in 2003. Prior to that, from 1998 to 2002, they attended HEC-ULg for Business Economics, but it does not specify if they obtained a degree. Additionally, they have obtained several certifications including "High potential accelerator" from Korn Ferry in 2019, "Leaders for the strategic future" from Legacy Transformational Consulting in 2019, "Medicines Australia Code of conduct" from the University of Tasmania in 2018, and "Impact and Influence: Driving outstanding results" from Ashridge Executive Education, Hult International Business School in 2014.